Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Evolving Research Landscape of Radiation Enteritis Prevention and Management: A Data-Driven Analysis.

Journal of inflammation research·2026

Same author

Predicting Treatment Response and Prognosis in Patients with Hepatocellular Carcinoma after Interventional Therapy [Letter].

Journal of hepatocellular carcinoma·2024

Same author

Dual-Channel Detection of Breast Cancer Biomarkers CA15-3 and CEA in Human Serum Using Dialysis-Silicon Nanowire Field Effect Transistor.

International journal of nanomedicine·2022

Same author

[A preliminary anatomical study on design of cannulated screw channels for fixation of symphysis pubis diastasis in small samples].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery·2014

Same author

Iterative image-domain decomposition for dual-energy CT.

Medical physics·2014

Same author

Lumbar spine stability after combined application of interspinous fastener and modified posterior lumbar interbody fusion: a biomechanical study.

Archives of orthopaedic and trauma surgery·2014

Search research articles

Related Experiment Videos

An Evolutionary Research Framework for the Tumor Microenvironment in Gastric Cancer.

Zhenlong Chen¹, Hang Li¹, Xiaosong Li¹

¹Department of General Surgery, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, Jiangsu, People's Republic of China.

Journal of Inflammation Research

|July 6, 2026

Summary

This study outlines an evolutionary framework for the tumor microenvironment (TME) in gastric cancer (GC), showing a shift from basic research to clinical applications like immunotherapy. Future research should integrate multi-omics and target inflammation for personalized GC therapy.

Keywords:

gastric cancer immunotherapy inflammatory microenvironment research evolution tumor microenvironment

Related Experiment Videos

Area of Science:

Oncology
Immunology
Bioinformatics

Background:

The tumor microenvironment (TME) is crucial in gastric cancer (GC) pathogenesis, progression, and treatment resistance.
Current research on GC's TME lacks a unified framework to integrate fragmented knowledge.
Understanding TME dynamics is key to advancing GC treatment strategies.

Purpose of the Study:

To construct an evolutionary framework for the TME in GC research.
To interpret developmental dynamics and identify paradigm shifts in TME research.
To guide future research directions for improved GC therapeutics.

Main Methods:

Systematic synthesis of the GC TME knowledge domain.
Construction of a comprehensive analytical framework.
Tracing the evolution of research themes and identifying paradigm shifts.

Main Results:

A "two-phase evolutionary framework" for GC TME research was proposed.
The field transitioned from basic mechanism exploration to translational integration, focusing on immunotherapy.
Current research emphasizes machine learning, prognostic models, immune evasion, and subtype-specific TME analysis.

Conclusions:

The study provides an evolutionary framework for GC TME research, highlighting the shift towards clinical targeting.
Future work should focus on multi-omics integration for precise prognostic/predictive models.
Targeting inflammatory pathways to overcome resistance and subtype-specific TME research for personalized therapy are recommended.